 NEWTOWN, Pa., Feb. 16, 2021 GLOBE NEWSWIRE -- Onconova Therapeutics, Inc. NASDAQ: ONTX Onconova, a biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that Steven Fruchtman, M.D., President CEO, will present a virtual Company update at the 2021 BIO CEO Investor Digital Conference being held February 16-18, 2021. Avi Oler, Senior VP, Corporate Development, will be available for 1x1 meetings scheduled through the Bio Partnering system. 